ANI Pharmaceuticals Targets $1B+ Sales in 2026, Pivots to Rare Disease Growth at Raymond James Conf.

ANI Pharmaceuticals outlined its strategic vision at the Raymond James Conference, aiming for over $1 billion in sales by 2026, with a key focus on expanding its presence in the rare disease market.